Boothbay Fund Management, LLC Biomea Fusion, Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$21.66 - $41.8 $238,411 - $460,092
11,007 Added 24.15%
56,592 $1.24 Million
Q1 2023

May 15, 2023
BUY
$6.8 - $32.35 $232,560 - $1.11 Million
34,200 Added 300.4%
45,585 $1.41 Million
Q4 2022

Feb 14, 2023
BUY
$6.3 - $11.6 $71,725 - $132,066
11,385 New
11,385 $95,000

Others Institutions Holding BMEA

# of Institutions
120
Shares Held
17.9M
Call Options Held
978K
Put Options Held
286K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $290M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email